Childerstone A, Altmann D, Haron J A, Wilkinson D, Trowsdale J, Lehner T
Department of Immunology, United Medical School of Guy's Hospital, London, UK.
J Immunol. 1991 Mar 1;146(5):1463-9.
T cells from most human subjects show significant in vitro proliferative responses to a 185-kDa surface Ag from Streptococcus mutans as well as to synthetic peptides derived from the sequence of a Mr 3800 streptococcal Ag. T cells from subjects expressing each of the alleles from DR1 to DR7 responded to synthetic peptides of 17 or 21 amino acid residues. Furthermore, inhibition studies with mAb to HLA class I and class II Ag showed that the DR Ag was a restriction molecule for the proliferative responses. Mouse L cells transfected with DR1, DR2, DR4, DR5, and DR7 were used to confirm the permissive nature of the responses. An analysis of the fine specificity of the responses showed that the minimum peptides capable of stimulating T cells from subjects with different DR types varied by one or two residues. For DR2 and DR3 the shortest peptide was residues 6-15, an additional serine (residue 5) was required for DR1 and DR7 and an aspartic acid (residue 4) for DR4, DR5, and DR6. Successful oral-mucosal bacterial colonisation in humans, by a largely commensal Streptococcus, might be associated with the permissive nature of the HLA-DR restriction of the response to a major streptococcal cell surface peptide. The peptide recognised in association with the HLA-DR molecule may induce an immune response that prevents central entry of the organism from the peripheral mucosal site.
大多数人类受试者的T细胞对变形链球菌的一种185 kDa表面抗原以及源自3800 Mr链球菌抗原序列的合成肽表现出显著的体外增殖反应。表达从DR1到DR7各等位基因的受试者的T细胞对17或21个氨基酸残基的合成肽有反应。此外,用抗HLA I类和II类抗原的单克隆抗体进行的抑制研究表明,DR抗原是增殖反应的限制分子。用转染了DR1、DR2、DR4、DR5和DR7的小鼠L细胞来证实反应的允许性质。对反应的精细特异性分析表明,能够刺激不同DR类型受试者T细胞的最小肽相差一两个残基。对于DR2和DR3,最短的肽是第6 - 15位残基,DR1和DR7需要额外的丝氨酸(第5位残基),DR4、DR5和DR6需要天冬氨酸(第4位残基)。人类口腔黏膜被一种主要为共生菌的链球菌成功定植,可能与对主要链球菌细胞表面肽反应中HLA - DR限制的允许性质有关。与HLA - DR分子结合识别的肽可能诱导一种免疫反应,阻止该生物体从外周黏膜部位进入体内。